Viatris, Inc. (VTRS)
16.52
+0.18
(+1.10%)
USD |
NASDAQ |
Aug 31, 16:00
16.52
0.00 (0.00%)
After-Hours: 20:00
Viatris Free Cash Flow : 1.806B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.806B |
| March 31, 2026 | 1.643B |
| December 31, 2025 | 1.851B |
| September 30, 2025 | 1.614B |
| June 30, 2025 | 1.710B |
| March 31, 2025 | 1.854B |
| December 31, 2024 | 1.944B |
| September 30, 2024 | 1.893B |
| June 30, 2024 | 1.884B |
| March 31, 2024 | 2.000B |
| December 31, 2023 | 2.325B |
| September 30, 2023 | 2.023B |
| June 30, 2023 | 2.045B |
| March 31, 2023 | 2.332B |
| December 31, 2022 | 2.510B |
| September 30, 2022 | 2.835B |
| June 30, 2022 | 3.035B |
| March 31, 2022 | 2.778B |
| December 31, 2021 | 2.508B |
| September 30, 2021 | 1.687B |
| June 30, 2021 | 1.22B |
| March 31, 2021 | 1.098B |
| December 31, 2020 | 550.60M |
| September 30, 2020 | 1.490B |
| June 30, 2020 | 1.448B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.738B |
| December 31, 2019 | 1.398B |
| September 30, 2019 | 1.499B |
| June 30, 2019 | 1.646B |
| March 31, 2019 | 1.406B |
| December 31, 2018 | 2.090B |
| September 30, 2018 | 1.883B |
| June 30, 2018 | 1.712B |
| March 31, 2018 | 1.369B |
| December 31, 2017 | 1.169B |
| September 30, 2017 | 888.80M |
| June 30, 2017 | 1.533B |
| March 31, 2017 | 1.764B |
| December 31, 2016 | 1.297B |
| September 30, 2016 | 1.654B |
| June 30, 2016 | 1.189B |
| March 31, 2016 | 852.50M |
| December 31, 2015 | 1.137B |
| September 30, 2015 | 714.90M |
| June 30, 2015 | 245.40M |
| March 31, 2015 | 401.00M |
| December 31, 2014 | 260.40M |
| September 30, 2014 | 611.91M |
| June 30, 2014 | 782.50M |
| March 31, 2014 | 804.30M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.99B |
| Eli Lilly & Co. | 13.56B |
| Merck & Co., Inc. | 16.06B |
| Bristol Myers Squibb Co. | 11.44B |
| Johnson & Johnson | 22.61B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 381.80M |
| Cash from Investing (Quarterly) | -51.60M |
| Cash from Financing (Quarterly) | -1.243B |
| Free Cash Flow Per Share (Quarterly) | 0.282 |
| Free Cash Flow to Equity (Quarterly) | 1.315B |
| Free Cash Flow to Firm (Quarterly) | 550.38M |
| Free Cash Flow Yield | 9.39% |